Clinical trials
Phase 2 Biliary Tract Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Basilea Pharmaceutica | 1 |
| Boehringer Ingelheim | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fore Biotherapeutics | 1 |
| Hoffmann-La Roche | 1 |
| Jazz Pharmaceuticals | 1 |
| Karus Therapeutics Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 16 |
| Cholangiocarcinoma | 5 |
| Colorectal Neoplasms | 3 |
| Gallbladder Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.